Tesaro raises $155M in private placement

Tesaro Inc. (NASDAQ:TSRO) raised $155 million through the sale of 4.4 million shares at $35.19 in a private placement. Kleiner Perkins Caufield & Byers and New Enterprise Associates each invested $50 million. New investors Australian Government Future Fund and Ally Bridge Group also participated, as did existing investor InterWest Partners.

In November, Tesaro launched Varubi rolapitant, an oral neurokinin 1 (NK1) substance P receptor ( TACR1) antagonist to treat chemotherapy-induced nausea and vomiting (CINV). ...